NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market Tuesday that its revenues for the first quarter were flat year over year.

For the three months ended Jan. 31, Agilent recorded $1.03 billion in revenues, beating the average Wall Street estimate of $1.02 billion.

"Agilent delivered a strong start to the year," Agilent President and CEO Mike McMullen said in a statement. "Revenue and earnings per share exceeded our guidance range, reflecting the strength of Agilent's products, services, and relationships with customers in our markets."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.